ANPEP and pachyonychia congenita: In conclusion, our results demonstrate that serum APN/CD13 could be potentially used to diagnose PC, especially early-stage disease; and high serum APN/CD13 levels were associated with more advanced clinicopathological features and poor outcome in PC patients.